Ernexa Therapeutics (ERNAW) Amortizatization of Intangibles (2019 - 2026)
Ernexa Therapeutics (ERNAW) reported Amortizatization of Intangibles of $78000.0 for Q1 2026, up 52.94% on a YoY basis from $51000.0 in Q1 2025, and up 39.29% quarter-over-quarter from $56000.0 in Q4 2025.
Ernexa Therapeutics (ERNAW) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Ernexa Therapeutics has reported Amortizatization of Intangibles for 7 years, with the latest figure at $78000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 52.94% year-over-year to $78000.0; the trailing twelve-month figure through Mar 2026 stood at $225000.0 (down 78.53% YoY), and the FY2025 full-year result was $198000.0, down 86.79% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $78000.0, up from $56000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $534000.0 in Q2 2024, with the low at $38000.0 in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $185294.1 across 5 years, with a median of $78000.0 in 2026.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles soared 1171.43% — and 2025, when it sank 92.88%.
- Ernexa Therapeutics' Amortizatization of Intangibles stood at $69000.0 in 2022, then surged by 565.22% to $459000.0 in 2023, then plunged by 89.32% to $49000.0 in 2024, then increased by 14.29% to $56000.0 in 2025, then surged by 39.29% to $78000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $78000.0 (Q1 2026), $56000.0 (Q4 2025), and $53000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 414,000.00 |
| Sep 30, 2024 | 414,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | 502,000.00 |
| Mar 31, 2024 | 502,000.00 |
| Dec 31, 2023 | 459,000.00 |
| Dec 31, 2023 | 459,000.00 |